Check out what we have in store for you in the September Mid-Month Newsletter

The Five: Cirrhosis

by Alan Franciscus, Editor-in-Chief

This month’s column is about cirrhosis—the causes, how it develops, the tests to identify it, the symptoms of cirrhosis and effect of hepatitis C treatment on cirrhosis and the effect of cirrhosis on treatment.

Snapshots: 

by Alan Franciscus, Editor-in-Chief

A review of three studies on treatment of hepatitis C in people coinfected with HIV—(1) ledipasvir and sofosbuvir, (2) grazoprevir and elbasvir and (3) daclatasvir and sofosbuvir.  All of these studies have very high cure rates.

HCV Advocate Drug Pipeline-Quarterly Report:

by Alan Franciscus, Editor-in-Chief

We have updated our drug pipeline into a very simple format that we will update quarterly. In addition to posting this with our newsletter, we will post it to the Treatment Issues page of the HCV Advocate website.

Disability & Benefits: Emotional Issues When Leaving Work on Disability

by Jacques Chambers, CLU

In this month’s column, Jacques explores the emotional issues of winning disability and leaving lifelong employment.

What’s New!

by Alan Franciscus, Editor-in-Chief

In addition to the launch of our website we are relaunching our social media!

Hepatitis C Training Workshop Schedule

Click here to read this issue

Share This Page
Follow Us